Skip to content

13F-HR filed by Jones Hill Capital LP

Jones Hill Capital LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 15:12:59 UTC, with 33 holding rows worth $589,169,587.

Accession
0002102314-26-000006
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 33 entries on the cover page, a total value of $589,169,587 stated on the cover page (in dollars after the unit check, H1), rows summing to $589,169,587 with VALUE read as dollars as filed, 13F file number 028-26921. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOMARIN PHARMACEUTICAL INC09061G101COM1,171,859$70,311,540dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock7,083,300$59,003,889dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM959,634$56,503,250dollars as filed
INDIVIOR PHARMACEUTICALS INC45579U109COM1,526,685$54,731,657dollars as filed
PHARVARIS NVN69605108COMMON STOCK987,637$31,327,846dollars as filed
CELCUITY INC15102K100COM382,901$30,448,288dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock599,826$26,782,231dollars as filed
SUPERNUS PHARMACEUTICALS868459108COM601,685$25,896,522dollars as filed
NUVATION BIO INC COM CL A67080N101Stock4,486,986$25,127,122dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK652,218$21,060,119dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock1,447,156$20,723,274dollars as filed
BICARA THERAPEUTICS INC055477103COM1,064,233$19,805,376dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK5,237,628$19,745,858dollars as filed
ABIVAX SA-00370M103SPONSORED ADS142,558$14,116,093dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock2,504,651$13,174,464dollars as filed
INSMED INC COM PAR $.01457669307Stock106,528$12,159,106dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM83,426$11,833,144dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR384,278$11,639,781dollars as filed
ERASCA INC COM29479A108Stock610,118$8,944,330dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK892,532$8,452,278dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM80,017$7,045,497dollars as filed
NEUROGENE INC64135M105COMMON STOCK217,700$6,056,414dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW886,428$6,045,439dollars as filed
TONIX PHARMACEUTICALS HOLDIN890260839COMMON STOCK563,739$5,490,818dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK502,587$4,965,560dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock300,900$4,847,499dollars as filed
AVALYN PHARMA INC05348Y105COMMON STOCK126,744$3,610,937dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM182,295$3,124,536dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK276,830$2,020,859dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK593,737$2,006,831dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM206,397$1,783,270dollars as filed
TENAX THERAPEUTICS INC88032L605COM NEW122,169$230,899dollars as filed
ALVOTECHL01800108ORDINARY SHARES26,700$154,860dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002102314-26-000006this filing2026-11-13